Stock Quote

Zeltia SA (ZEL.MC) (Madrid SE C.A.T.S.)
As of  11:35am EST
4.11EUR
Price Change
+0.05
Percent Change
+1.11%
 
€4.11
11:35am EST
+1.11%
€4.06
€4.00
626,001
€4.14
€3.91
€5.67
€2.33
0.75
529,064

Research Another Stock: Symbol Look-up
Zeltia's Nypta gets orphan drug status, shares gain
Tuesday, 3 Nov 2009 03:30am EST 
Zeltia's Nypta receives orphan drug status
Tuesday, 3 Nov 2009 02:47am EST 
Zeltia gets final EU okay for Yondelis drug
Monday, 2 Nov 2009 04:14am EST 
Spanish stocks - Factors to watch on Thursday
Thursday, 8 Oct 2009 02:28am EDT 
Spain's Zeltia says no need to expand capital
Wednesday, 7 Oct 2009 01:21pm EDT 
 
Name Current Position Compensation
Fernandez Sousa-Faro, Jose Maria Chairman of the Board --
Fernandez Puentes, Pedro Vice Chairman of the Board --
De Francia Caballero, Maria Luisa Chief Financial Officer --

Profile

Zeltia SA is a Spain-based holding company primarily engaged, through its subsidiaries, in the chemical and pharmaceutical sectors. Its main subsidiaries are: PharmaMar SA, biopharmaceutical company committed to advancing the treatment of cancer; Noscira SA, engaged in the research and development... Full Description

Company Web Links

Company Address

Zeltia SA
C/ Jose Abascal 2
Madrid   MAD   28003
P: +3491.4444500
F: +3491.5932954

Analyst Research

  ZEL.MC Industry
P/E(TTM) -- 4.64
P/S(TTM) 6.27 0.16
ROI(TTM) -21.93 0.05
ROE(TTM) -55.35 0.10
Consensus Recommendation Hold
EPS Est. (Current Period) --
EPS Est. (Current Year) -0.11
Total Revenue $37.33M
Net Income $-8.18M
EPS $-0.04